Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1182 of 5804
-
New collagen scaffold helps rebuild breasts after cancer surgery
Disease control CompletedThis clinical trial evaluates the safety and efficacy of High Purity Type I Collagen scaffold for breast volume restoration following breast-conserving surgery (BCS). The regenerative collagen matrix serves as a biocompatible scaffold promoting tissue ingrowth, neovascularization…
Phase: NA • Sponsor: Adichunchanagiri Institute of Medical Sciences, B G Nagara • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New combo therapy aims to freeze and burn liver cancer
Disease control Recruiting nowMultimodal thermal therapy (MTT), as an initiative integration of cryotherapy and radiofrequency heating, has been applied to treat various solid tumors. The feasibility and safety for MTT in the treatment of malignant liver tumors is well-established. This prospective, multi-cen…
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Hearing aid trial aims to calm agitation in Alzheimer's patients
Symptom relief Recruiting nowThis randomized controlled trial study aims to evaluate a revised hearing care intervention for older adults with Alzheimer's Disease and Related Dementias (ADRD). The community-delivered hearing care intervention utilizes tailored strategies to assess impact on communication, ne…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Brain zaps aim to unlock better walking for MS patients
Symptom relief Recruiting nowStudy the impact of rTMS on walking ability in people with Multiple Sclerosis (MS) induced spastic paraparesis and moderate walking disability.
Phase: NA • Sponsor: Clinique Neuro-Outaouais • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New hope for cervical cancer? drug cocktail targets tumors that resist immunotherapy
Disease control Not yet recruitingThis is a clinical research study for women with recurrent or metastatic cervical cancer whose disease has progressed after prior treatment with a PD-1/PD-L1 inhibitor immunotherapy. The study will evaluate the effectiveness and safety of a new combination treatment consisting o…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Video games with AI could boost brain and body recovery after stroke
Symptom relief Not yet recruitingthis study will be conducted to investigate the effect of artificial intelligence based gamification training on cognition and functional outcomes in patients with stroke
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New drug before prostate surgery aims to wipe out hidden cancer cells
Disease control Not yet recruitingReal-world study on Preoperative Application of Rezvilutamide
Sponsor: Shanghai Pudong New Area Gongli Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New cell therapy for MS enters human safety testing
Disease control OngoingThis study aims to explore the safety, tolerability, cellular kinetics, and pharmacodynamics of P-CD19CD20-ALLO1 in participants with progressive multiple sclerosis (PMS) and relapsing multiple sclerosis (RMS).
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug combo aims to fight Hard-to-Treat cancers
Disease control Not yet recruitingThis is a Phase 1, open-label, dose-escalation and cohort expansion study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of IMM2510(Anti-PD-L1 and VEGF trap recombinant protein) combine with IMM01(Anti-CD47 Recombinant Protein)…
Phase: PHASE1, PHASE2 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:39 UTC
-
New study tests if keyhole spine surgery can beat traditional scoliosis operation
Disease control Not yet recruitingSurgical treatment for idiopathic scoliosis usually involves open surgery from the back (posterior approach). This method corrects the curve and stabilizes the spine using screws and rods, followed by a fusion of the treated segments. The goal is to achieve the best possible alig…
Phase: NA • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Virtual rehab hub aims to cut surgery complications for colorectal cancer patients
Disease control Recruiting nowObjectives: The primary aim of this project is to establish the effectiveness of an individualised stepped, multidisciplinary intervention, including education and peer support group, delivered via a virtual multimodal (p)rehabilitation hub, in reducing postoperative complicatio…
Phase: NA • Sponsor: Surgical Outcomes Research Centre (SOuRCe) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
AI reads baby brain scans: could it spot problems doctors miss?
Diagnosis OngoingTimely detection of fetal brain anomalies is critical for improving prenatal counseling and postnatal neurological outcomes. Ultrasonography is the most commonly used and effective imaging method for evaluating fetal structures; however, diagnostic accuracy can be affected by ope…
Sponsor: Sanliurfa Mehmet Akif Inan Education and Research Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
AI-Powered home rehab could transform stroke recovery
Symptom relief Recruiting nowThe AISN multicenter randomized controlled trial will assess the effectiveness of a novel artificial intelligence (AI)-based clinical decision-support system integrated into the Rehabilitation Gaming System (RGS) for home-based post-stroke rehabilitation. Approximately 192 partic…
Phase: NA • Sponsor: Eodyne Systems SL • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New hope for endometriosis sufferers: drug trial targets pelvic pain
Symptom relief Recruiting nowThe main objective of the trial is to evaluate the efficacy of vipoglanstat on endometriosis-related non-menstrual pelvic pain (NMPP).
Phase: PHASE2 • Sponsor: Gesynta Pharma AB • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New rapid test could save lives from toxic chinese herb poisoning
Diagnosis Recruiting nowAconitine and related alkaloids are potent cardiotoxins and neurotoxins found in the Aconitum species used in traditional Chinese medicine (TCM), such as 'Chuanwu', 'Caowu' and 'Fuzi'. They pose significant health risks when used inappropriately without professional supervision. …
Sponsor: The University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Can a cancer drug tame rare bleeding Disorder's heart complications?
Disease control ENROLLING_BY_INVITATIONHigh cardiac output secondary to hepatic arteriovenous malformations may be isolated or associated with left heart failure with post-capillary pulmonary hypertension. More rarely, precapillary pulmonary hypertension develops, linked to obstructive pulmonary arterial remodeling, r…
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New pill offers hope for fingers that turn white and blue in the cold
Symptom relief Recruiting nowRaynaud's phenomenon is a condition where the blood vessels in participants fingers and toes get too narrow when cold or stressed. This makes participants fingers and toes change colors - they might turn white, then blue, and finally red as blood flow returns. It can be painful a…
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can community action and cash help end violence against women? malawi trial aims to find out
Prevention Recruiting nowViolence against women is complex and must be addressed at multiple levels, with leadership from women themselves on how to bring about positive change to free women and girls from daily experiences of violence and to promote their rights. It is in this context that the Pamodzi K…
Phase: NA • Sponsor: George Washington University • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Fasting two days a week could shrink fatty liver, new study hopes to prove
Disease control Recruiting nowThe recommended treatment for metabolic dysfunction-associated steatotic liver disease (MASLD) currently focuses on lifestyle changes, including dietary adjustments and increased physical activity. Intermittent fasting is a specific dietary approach in which food intake is restri…
Phase: NA • Sponsor: Universität des Saarlandes • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Wall squats may lower blood pressure and slow artery damage, new study suggests
Disease control Recruiting nowBackground: Hypertension (HT) is the most common condition worldwide, predisposing to atherosclerotic disease. However, most HT patients have suboptimal BP control despite anti-HT medications. Isometric resistance exercise (IRE) (e.g. wall squat) may improve BP control, characte…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC